{"id":"comparator-dexamethasone","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Insomnia and mood disturbances"},{"rate":null,"effect":"Increased infection risk"},{"rate":null,"effect":"Osteoporosis (with chronic use)"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Cushingoid features (with chronic use)"}]},"_chembl":{"chemblId":"CHEMBL1697787","moleculeType":"Small molecule","molecularWeight":"528.57"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dexamethasone acts as a potent corticosteroid that inhibits phospholipase A2, reducing prostaglandin and leukotriene production, and suppresses T-cell and B-cell proliferation. It decreases inflammatory cytokine production and increases anti-inflammatory mediators, making it effective for reducing inflammation and immune-mediated responses across multiple organ systems.","oneSentence":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:03.087Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis)"},{"name":"Cerebral edema and increased intracranial pressure"},{"name":"Severe allergic reactions and anaphylaxis"},{"name":"Adrenocortical insufficiency"},{"name":"Supportive care in cancer therapy (chemotherapy-induced nausea and vomiting, prevention of hypersensitivity reactions)"}]},"trialDetails":[{"nctId":"NCT06892522","phase":"PHASE1, PHASE2","title":"A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; Carfilzomib","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-06-30","conditions":"Multiple Myeloma","enrollment":440},{"nctId":"NCT05488847","phase":"PHASE4","title":"Opioid-Free Pain Protocol After Shoulder Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-25","conditions":"Shoulder Arthropathy, Shoulder Pain","enrollment":83},{"nctId":"NCT07151027","phase":"NA","title":"Effectiveness Of Alcohol Addition In Ultrasound-Guided Periarticular Sacroiliac Joint Injection","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-08-25","conditions":"Sacro Iliac Joint Pain, Low Back Pain, Alcohol Induced Neurolysis","enrollment":54},{"nctId":"NCT07113158","phase":"PHASE3","title":"Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-04-01","conditions":"Sudden Sensorineural Hearing Loss","enrollment":142},{"nctId":"NCT06936449","phase":"","title":"Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array","status":"RECRUITING","sponsor":"Cochlear","startDate":"2025-05-05","conditions":"Sensorineural Hearing Loss, Bilateral Hearing Loss","enrollment":19},{"nctId":"NCT04469491","phase":"PHASE2","title":"Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2020-09-20","conditions":"COVID-19, INTERFERON, NEBULIZATION","enrollment":74},{"nctId":"NCT06953635","phase":"NA","title":"Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair","status":"NOT_YET_RECRUITING","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2025-06-01","conditions":"Hernia, Ventral, Pain Management","enrollment":70},{"nctId":"NCT04750642","phase":"NA","title":"Cochlear Implant With Dexamethasone Eluting Electrode Array","status":"COMPLETED","sponsor":"Cochlear","startDate":"2021-10-04","conditions":"Sensorineural Hearing Loss, Bilateral Hearing Loss","enrollment":42},{"nctId":"NCT04418999","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus","status":"COMPLETED","sponsor":"Illinois College of Optometry","startDate":"2020-09-01","conditions":"Keratoconus, Dry Eye, Allergy","enrollment":36},{"nctId":"NCT05101928","phase":"PHASE4","title":"Ozurdex Monotherapy Trial","status":"WITHDRAWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2021-11-30","conditions":"Uveitis, Posterior, Uveitis, Intermediate, Panuveitis","enrollment":""},{"nctId":"NCT01277289","phase":"PHASE3","title":"Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease","status":"TERMINATED","sponsor":"Quince Therapeutics S.p.A.","startDate":"2009-06-03","conditions":"Crohn's Disease","enrollment":51},{"nctId":"NCT05416255","phase":"NA","title":"Measuring Synovial Fluid Components","status":"UNKNOWN","sponsor":"Dharma Bioscience","startDate":"2022-04-01","conditions":"Knee Osteoarthritis","enrollment":80},{"nctId":"NCT01626664","phase":"PHASE2","title":"KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)","status":"COMPLETED","sponsor":"Kyowa Kirin, Inc.","startDate":"2012-06","conditions":"Adult T-cell Leukemia-Lymphoma","enrollment":71},{"nctId":"NCT06107660","phase":"PHASE4","title":"Utility of Exparel Based ESP Blocks in Elective Posterior Spine Fusion","status":"UNKNOWN","sponsor":"Hartford Hospital","startDate":"2023-12","conditions":"Spine Fusion, Anesthesia, Local","enrollment":100},{"nctId":"NCT04208516","phase":"PHASE4","title":"Continuous Nerve Block Block vs Combination of Single Block Plus Intravenous Lidocaine for Postoperative Pain.","status":"TERMINATED","sponsor":"Jeremy Kearns","startDate":"2021-05-26","conditions":"Postoperative Pain","enrollment":17},{"nctId":"NCT04561180","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia","status":"WITHDRAWN","sponsor":"Evergreen Therapeutics, Inc.","startDate":"2022-03-04","conditions":"COVID-19 Pneumonia","enrollment":""},{"nctId":"NCT01850524","phase":"PHASE3","title":"IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma","status":"COMPLETED","sponsor":"Millennium Pharmaceuticals, Inc.","startDate":"2013-04-29","conditions":"Multiple Myeloma","enrollment":705},{"nctId":"NCT04860518","phase":"PHASE2","title":"Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19","status":"TERMINATED","sponsor":"Faron Pharmaceuticals Ltd","startDate":"2021-08-23","conditions":"Covid19","enrollment":7},{"nctId":"NCT04926571","phase":"","title":"Dexamethasone and COVID-19 Inpatient Mortality","status":"COMPLETED","sponsor":"Aetion, Inc.","startDate":"2020-04-01","conditions":"Coronavirus","enrollment":14105},{"nctId":"NCT02544308","phase":"PHASE3","title":"Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University College, London","startDate":"2017-03-10","conditions":"Plasmacytoma","enrollment":36},{"nctId":"NCT04019834","phase":"EARLY_PHASE1","title":"Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2020-07-06","conditions":"Breast Cancer, Mastectomy, Anesthesia, Local","enrollment":21},{"nctId":"NCT04724629","phase":"PHASE3","title":"Survival TRial Using CytoKines in COVID-19 (STRUCK Trial)","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2021-01-05","conditions":"Covid19","enrollment":60},{"nctId":"NCT03954379","phase":"PHASE4","title":"IPACK Study in Total Knee Arthroplasty Patients","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2019-10-24","conditions":"Knee Replacement Arthroplasty","enrollment":78},{"nctId":"NCT04452565","phase":"PHASE2, PHASE3","title":"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection","status":"UNKNOWN","sponsor":"Biomed Industries, Inc.","startDate":"2022-06-15","conditions":"Coronavirus Infection, Severe Acute Respiratory Infection, Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":525},{"nctId":"NCT04631536","phase":"PHASE3","title":"Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC","status":"UNKNOWN","sponsor":"Lebanese American University Medical Center","startDate":"2021-01-10","conditions":"Covid19","enrollment":42},{"nctId":"NCT04869579","phase":"PHASE2","title":"Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.","status":"UNKNOWN","sponsor":"CHRISTUS Health","startDate":"2021-08-15","conditions":"Covid19","enrollment":100},{"nctId":"NCT04486521","phase":"","title":"Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19","status":"UNKNOWN","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2020-07-22","conditions":"Critical Illness, Corona Virus Infection, Cytokine Release Syndrome","enrollment":860},{"nctId":"NCT01857232","phase":"PHASE2","title":"Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy","status":"COMPLETED","sponsor":"Acacia Pharma Ltd","startDate":"2013-10","conditions":"CINV","enrollment":342},{"nctId":"NCT02266433","phase":"PHASE3","title":"Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2012-08","conditions":"DeQuervains Tenosynovitis, Lateral Epicondylitis, Tennis Elbow","enrollment":245},{"nctId":"NCT01639599","phase":"NA","title":"Optimal Haloperidol Dose for Postoperative Nausea and Vomiting Prevention in High-risk Patients","status":"COMPLETED","sponsor":"The Catholic University of Korea","startDate":"2012-03","conditions":"Gynecological Disease","enrollment":150},{"nctId":"NCT03769818","phase":"NA","title":"Role of Dexamethasone for Erector Spinae Plane Block in Patients Undergoing Total Abdominal Hysterectomy","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2019-01-01","conditions":"Postoperative Pain","enrollment":150},{"nctId":"NCT03767920","phase":"NA","title":"Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2019-01-01","conditions":"Cesarean Section","enrollment":120},{"nctId":"NCT02861859","phase":"PHASE3","title":"Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2016-12","conditions":"Breast Cancer","enrollment":221},{"nctId":"NCT01602224","phase":"PHASE2","title":"A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-07","conditions":"Multiple Myeloma","enrollment":220},{"nctId":"NCT01545700","phase":"PHASE4","title":"Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery","status":"COMPLETED","sponsor":"Endeavor Health","startDate":"2009-09","conditions":"Postoperative Complications","enrollment":200},{"nctId":"NCT01697579","phase":"PHASE2","title":"Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-12-13","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":240},{"nctId":"NCT02864602","phase":"PHASE3","title":"IV Dexamethasone for Prolongation of Peripheral Nerve Block","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2016-11-12","conditions":"Anesthesia, Conduction","enrollment":18},{"nctId":"NCT00818259","phase":"PHASE1","title":"A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-02-05","conditions":"Chemotherapy-Induced Nausea and Vomiting","enrollment":92},{"nctId":"NCT01594749","phase":"PHASE3","title":"Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2012-09-24","conditions":"Chemotherapy-Induced Nausea and Vomiting (CINV)","enrollment":1015},{"nctId":"NCT01206387","phase":"PHASE3","title":"Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2010-08","conditions":"Psoriasis","enrollment":120},{"nctId":"NCT00952341","phase":"PHASE3","title":"Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-08-25","conditions":"Chemotherapy-induced Nausea and Vomiting (CINV)","enrollment":421},{"nctId":"NCT00337727","phase":"PHASE3","title":"Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-01-01","conditions":"Chemotherapy-Induced Nausea and Vomiting","enrollment":848},{"nctId":"NCT00619359","phase":"PHASE3","title":"Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-02","conditions":"Chemotherapy-Induced Nausea and Vomiting (CINV)","enrollment":2322},{"nctId":"NCT01007500","phase":"PHASE4","title":"Effect of Dexamethasone Combined With Ondansetron on Postoperative Nausea and Vomiting in Patients With Patient-controlled Analgesia After Video-assisted Thoracoscopic Surgery","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2009-09","conditions":"Nausea, Vomiting","enrollment":123},{"nctId":"NCT02510157","phase":"NA","title":"Effect of Dexamethasone on the Action of Sugammadex","status":"COMPLETED","sponsor":"Attikon Hospital","startDate":"2015-05","conditions":"Neuromuscular Blockade","enrollment":44},{"nctId":"NCT02735317","phase":"PHASE2","title":"Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT","status":"UNKNOWN","sponsor":"Yun-fei Xia","startDate":"2016-04","conditions":"Nasopharyngeal Neoplasms, Stomatitis","enrollment":90},{"nctId":"NCT02478047","phase":"NA","title":"Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting","status":"UNKNOWN","sponsor":"Tianjin University of Traditional Chinese Medicine","startDate":"2015-06","conditions":"Chemotherapy-induced Nausea and Vomiting","enrollment":240},{"nctId":"NCT00891761","phase":"PHASE3","title":"A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2009-09","conditions":"Cancer, Chemotherapy-Induced Nausea and Vomiting, Nausea and Vomiting","enrollment":""},{"nctId":"NCT01396057","phase":"PHASE3","title":"Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-07","conditions":"Visual Impairment, Macular Edema, Branch Retinal Vein Occlusion","enrollment":244},{"nctId":"NCT01001091","phase":"PHASE2","title":"AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2009-12","conditions":"Allergic Conjunctivitis","enrollment":312},{"nctId":"NCT02142543","phase":"EARLY_PHASE1","title":"The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2012-03","conditions":"Minor Recurrent Aphthous Stomatitis Lesions","enrollment":23},{"nctId":"NCT02026479","phase":"NA","title":"Sudden Hearing Loss Multi-center Clinical Trial","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2014-01","conditions":"Full-frequency Sudden Hearing Loss","enrollment":300},{"nctId":"NCT01836575","phase":"PHASE3","title":"Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2","status":"COMPLETED","sponsor":"Instituto Nacional de Cancer, Brazil","startDate":"2008-04","conditions":"Non Small Cell Lung Carcinoma","enrollment":228},{"nctId":"NCT01227863","phase":"PHASE3","title":"Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis","status":"UNKNOWN","sponsor":"Azidus Brasil","startDate":"2011-02","conditions":"Bacterial Conjunctivitis, Acute","enrollment":70},{"nctId":"NCT01227915","phase":"PHASE3","title":"Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis","status":"UNKNOWN","sponsor":"Azidus Brasil","startDate":"2011-02","conditions":"Acute Bacterial Conjunctivitis","enrollment":70},{"nctId":"NCT00835965","phase":"NA","title":"Oral Aprepitant and Lower Dose Dexamethasone Versus Aprepitant Alone for Preventing Postoperative Nausea and Vomiting (PONV) After Elective Laparoscopic Surgeries","status":"UNKNOWN","sponsor":"Main Line Health","startDate":"2009-02","conditions":"Nausea, Vomiting","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":20826,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DEXAMETHASONE TABLETS USP"],"phase":"phase_3","status":"active","brandName":"Comparator: dexamethasone","genericName":"Comparator: dexamethasone","companyName":"Merck Sharp & Dohme LLC","companyId":"merck-sharp-dohme-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors. Used for Inflammatory and autoimmune disorders (rheumatoid arthritis, lupus, vasculitis), Cerebral edema and increased intracranial pressure, Severe allergic reactions and anaphylaxis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}